Anti-PD1 抗体 [NAT105]
Anti-PD1 antibody [NAT105]
- BOND RX™ Validated
- Recombinant
- 詳細を見る
5
(9 Reviews)
|
(328 Publications)
Anti-PD1 antibody [NAT105] (ab52587) is a mouse monoclonal antibody detecting PD1 in Western Blot, Flow Cytometry, IHC-P, IHC-Fr, ICC/IF. Suitable for Human.
- Over 280 publications
- Trusted since 2007
別名を表示する
CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, hPD-1
- IHC-Fr
Supplier Data
Immunohistochemistry (Frozen sections) - Anti-PD1 antibody [NAT105] (AB52587)
Immunohistochemical analysis of permeabilized frozen Human tonsil tissue labeling PD1 with ab52587 at 1/10000 dilution, followed by LeicaDS9800 (Bond™ PolymerRefine Detection). Counterstained with hematoxylin. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- IHC-Fr
Supplier Data
Immunohistochemistry (Frozen sections) - Anti-PD1 antibody [NAT105] (AB52587)
Immunohistochemical analysis of permeabilized frozen Human cardiac muslce tissue labeling PD1 with ab52587 at 1/10000 dilution, followed by LeicaDS9800 (Bond™ PolymerRefine Detection). No staining on human cardiac muscle. Counterstained with hematoxylin. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- mIHC
Collaborator
Multiplex immunohistochemistry - Anti-PD1 antibody [NAT105] (AB52587)
10-color fluorescence multiplex immunohistochemical analysis of human lung cancer tissue (formalin-fixed paraffin-embedded section).
Merged staining of anti-FOXP3 (ab215206; Cyan; TG540N), anti-PD1 (ab52587; Red; TG700N), anti-CD163 (ab182422; Brown; TG650N), anti-HLA-DR (ab92511; Yellow; TG570N), anti-CD4 (ab133616; Violet; TG620N), anti-CD8 alpha (ab101500; Purple; TG540S), anti-CD20 (ab9475; Grey; TG660S), anti-CD68 (ab192847; Green; TG520N), anti-Cytokeratin 19 (ab52625; Light blue; TG440N). TG470SN (dark blue) was used as a nuclear counter stain. The inset image shows the separate CD68 signal.
The section was incubated in nine rounds of staining; in the order of ab215206 (1/100 dilution), ab52587 (1/200 dilution), ab182422 (1/300 dilution), ab92511 (1/200 dilution), ab133616 (1/600 dilution), ab101500 (1/300 dilution), ab9475 (1/100 dilution), ab192847 (1/300 dilution), ab52625 (1/400 dilution); each using a separate fluorescent tyramide signal amplification system.
Sodium citrate antigen retrieval (pH6.0) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity.
Image acquisition was performed with TissueFAXS Spectra (TissueGnostics).
This image is courtesy of TissueGnostics Asia Pacific Limited
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-PD1 antibody [NAT105] (AB52587)
Cells were fixed with 100µl 4% PFA for 10 min at RT, then permeabilized with 100µl 90% methanol for 30 min (-20° C) followed by blocking with 10% goat serum for 1h at room temperature. Incubate ab52587 for 30 min at room temperature (RT) and then incubate Goat anti-Mouse IgG (Alexa Fluor® 488, ab150113) for 30 min at room temperature. Positive staining on MOLT-4 treated with 10ng/ml PMA and 500ng/ml Ionomycin for 24h, but weak staining on untreated MOLT-4.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD1 antibody [NAT105] (AB52587)
Immunohistochemical analysis of paraffin-embedded Human cardiac muscle tissue labeling PD1 with ab52587 at 1/100 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). No staining on human cardiac muscle. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PD1 antibody [NAT105] (AB52587)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized MOLT-4 cells labelling PD1 with ab52587 at 1/100 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (ab150117) at 1/1000 dilution at RT for 45 min. Recombinant Alexa Fluor® 594 Anti-beta Tubulin antibody [EPR16774] (ab206369) was used as a counterstain at 1/50 dilution and was co-incubated with ab52587 overnight at 4° C. Nucleus were visualized using DAPI. Confocal image showing membranous staining in MOLT-4 cells treated with 500 ng/ml Ionomycin and 10 ng/ml Phorbol-12-myristate-13-acetate (PMA) for 24 hours, and no staining in MOLT-4 cells.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD1 antibody [NAT105] (AB52587)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling PD1 with ab52587 at 1/100 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins.
- WB
Supplier Data
Western blot - Anti-PD1 antibody [NAT105] (AB52587)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-PD1 antibody [NAT105] (ab52587) at 1/1000 dilution
Lane 1:
Untreated MOLT-4 (human lymphoblastic leukemia T lymphoblast) whole cell lysate at 20 µg
Lane 2:
MOLT-4 treated with 500ng/ml Ionomycin and 10ng/ml Phorbol-12-myristate-13-acetate (PMA) for 24 hours, whole cell lysate at 20 µg
false
- IHC-P
CiteAb
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD1 antibody [NAT105] (AB52587)
PD1 Immunohistochemistry using Anti-PD1 antibody [NAT105] ab52587. Publication image and figure legend from Kaewkangsadan, V., Verma, C., et al. 2016, J Immunol Res, PubMed 27777963.
PD-1+ T cells in the sections of LLABCs, using IHC staining, at 400x magnification. Briefly, heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections were then incubated with MAbs to PD-1 (Abcam, ab52587) at a 1 : 100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualize the staining. The sections were counterstained with haematoxylin. (a) Low level of PD-1+ T cell infiltration; (b) high level of PD-1+ T cell infiltration. The average number of brown membrane-stained cells, regardless of intensity, in contact with tumour cells or within tumour cell nests (Itu : intratumoural) and in the interstitial stroma (Str : stromal) per HPF was counted.
- WB
CiteAb
Western blot - Anti-PD1 antibody [NAT105] (AB52587)
PD1 western blot using Anti-PD1 antibody [NAT105] ab52587. Publication image and figure legend from Zhao, Z., Shi, L., et al., 2018, Oncotarget, PubMed 29435173.
CTLs isolation and PD-1 knockout(A) The percentage of CD3+/CD8+ cells (CTLs) reached 95% after negative selection. (B) The CTLs were transduced with lentivirus co-expressing Cas9 and each of the indicated guide RNA. The expression of PD-1 guide RNA reduced the PD-1 expression in the transduced cells.
false
関連する標識済み抗体及び組成の異なる製品 (4)
-
Anti-PD1 antibody [NAT105] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PD1 antibody [NAT105]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PD1 antibody [NAT105]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PD1 antibody [NAT105]
Reactivity data
製品の詳細
Anti-PD1 antibody [NAT105] (ab52587) is a mouse recombinant monoclonal antibody and is validated for use in Flow Cyt, ICC/IF, IHC-Fr, IHC-P and WB.
Anti-PD1 antibody [NAT105] (ab52587) was first used in a scientific publication in 2007 and has been cited over 282 times in peer reviewed journals. It's performance in IHC in human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-PD1 antibody [NAT105] (ab52587) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-PD1 antibody [NAT105] (ab52587) has 8 independent reviews from customers.
Anti-PD1 antibody [NAT105] (ab52587) specifically detects PD1 (UniProt ID: Q15116; Molecular weight: 29kDa) and is sold in a convenient trial size to enable initial testing (20 µg) and larger sizes for subsequent scaling up experiments (100 ug and 1 mg).
Conjugation-ready, carrier free format available for antibody clone NAT105 - ab201811.
Antibody clone NAT105 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, PE, Alexa Fluor® 647, Alexa Fluor® 555 (ab220300, ab220301, ab220302, ab279695, ab280864).
PD-1 is an immune checkpoint receptor that, when engaged by its ligands PD-L1 or PD-L2, inhibits T-cell activity, allowing tumors to evade immune detection. Blocking the PD-1 pathway with immune checkpoint inhibitors reactivates T-cells, enhancing the immune system's ability to target and destroy cancer cells.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD-1 serves as a critical immune checkpoint that helps maintain self-tolerance and prevent autoimmunity. PD-1 does not function as part of a multi-protein complex but independently regulates the immune response. By delivering inhibitory signals upon ligand binding PD-1 limits the overactivation of the immune system reducing the likelihood of tissue damage during inflammatory responses. The modulation of T cell activity by PD-1 contributes to a balanced immune system ensuring that the body targets pathogens effectively without harming itself.
Pathways
PD-1 interacts with key immune-regulatory pathways including the PI3K-Akt and Ras-MAPK pathways. These pathways are important for cell survival growth and metabolism. The interaction of PD-1 with the PI3K-Akt pathway involves proteins such as SHP-2 which dephosphorylates signaling intermediates leading to reduced T cell receptor signaling. PD-1's role in these pathways demonstrates its influence on immune cell function particularly in regulating the intensity and duration of immune responses.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (328)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:1056 PubMed41053808
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCO precision oncology 9:e2500404 PubMed40749151
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 13: PubMed40744660
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed40643462
2025
Applications
Unspecified application
Species
Unspecified reactive species
International dental journal 75:100874 PubMed40570672
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2025:6217272 PubMed40568348
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1618487 PubMed40568593
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer genomics & proteomics 22:496-509 PubMed40280722
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of medical research 30:242 PubMed40186294
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical science 32:11 PubMed39838427
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com